| 2025 |
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study |
Articolo in rivista |
Go to |
| 2024 |
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors |
Review essay (rassegna critica) |
Go to |
| 2024 |
Scientific Communication and oncology – "The bridge between knowledge and patients" |
Review essay (rassegna critica) |
Go to |
| 2024 |
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints |
Review essay (rassegna critica) |
Go to |
| 2024 |
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? |
Articolo in rivista |
Go to |
| 2023 |
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer |
Articolo in rivista |
Go to |
| 2023 |
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay |
Articolo in rivista |
Go to |
| 2023 |
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? |
Articolo in rivista |
Go to |
| 2023 |
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? |
Articolo in rivista |
Go to |
| 2022 |
Liquid biopsy and immunotherapy: is all that glitter gold? |
Capitolo o Saggio |
Go to |
| 2022 |
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? |
Articolo in rivista |
Go to |
| 2022 |
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer |
Articolo in rivista |
Go to |
| 2022 |
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? |
Articolo in rivista |
Go to |
| 2022 |
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength |
Articolo in rivista |
Go to |
| 2022 |
MUTYH-associated tumor syndrome: The other face of MAP |
Articolo in rivista |
Go to |
| 2022 |
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning |
Articolo in rivista |
Go to |
| 2021 |
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors |
Review essay (rassegna critica) |
Go to |
| 2021 |
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge |
Articolo in rivista |
Go to |
| 2021 |
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome |
Articolo in rivista |
Go to |
| 2021 |
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology |
Articolo in rivista |
Go to |
| 2021 |
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) |
Articolo in rivista |
Go to |
| 2021 |
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? |
Articolo in rivista |
Go to |
| 2021 |
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon |
Articolo in rivista |
Go to |
| 2021 |
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes |
Review essay (rassegna critica) |
Go to |
| 2020 |
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 |
Articolo in rivista |
Go to |
| 2020 |
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions |
Articolo in rivista |
Go to |
| 2020 |
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming |
Articolo in rivista |
Go to |
| 2020 |
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients |
Articolo in rivista |
Go to |
| 2020 |
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes |
Articolo in rivista |
Go to |
| 2019 |
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? |
Review essay (rassegna critica) |
Go to |
| 2019 |
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma |
Articolo in rivista |
Go to |
| 2019 |
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) |
Review essay (rassegna critica) |
Go to |
| 2019 |
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? |
Articolo in rivista |
Go to |
| 2019 |
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 |
Articolo in rivista |
Go to |
| 2019 |
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2018 |
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells |
Articolo in rivista |
Go to |
| 2018 |
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review |
Articolo in rivista |
Go to |
| 2018 |
Circular RNA in Exosomes |
Capitolo o Saggio |
Go to |
| 2017 |
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin |
Articolo in rivista |
Go to |
| 2017 |
Liquid Biopsy in Gastrointestinal Stromal Tumor |
Capitolo o Saggio |
Go to |
| 2017 |
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer |
Articolo in rivista |
Go to |
| 2017 |
Effects of Dietary Restriction on Cancer Development and Progression |
Capitolo o Saggio |
Go to |
| 2017 |
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2017 |
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway |
Articolo in rivista |
Go to |
| 2016 |
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? |
Articolo in rivista |
Go to |
| 2016 |
A headlight on liquid biopsies: a challenging tool for breast cancer management |
Articolo in rivista |
Go to |
| 2016 |
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway |
Review essay (rassegna critica) |
Go to |
| 2016 |
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus |
Articolo in rivista |
Go to |
| 2016 |
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma |
Articolo in rivista |
Go to |
| 2016 |
Dietary restriction: could it be considered as speed bump on tumor progression road? |
Articolo in rivista |
Go to |
| 2016 |
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines |
Proceedings |
Go to |
| 2016 |
Non-coding RNAs functioning in colorectal cancer stem cells |
Capitolo o Saggio |
Go to |
| 2016 |
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer |
Capitolo o Saggio |
Go to |
| 2016 |
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? |
Articolo in rivista |
Go to |
| 2016 |
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? |
Articolo in rivista |
Go to |
| 2015 |
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? |
Articolo in rivista |
Go to |
| 2015 |
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? |
Articolo in rivista |
Go to |
| 2015 |
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? |
Articolo in rivista |
Go to |
| 2014 |
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer |
Articolo in rivista |
Go to |
| 2014 |
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? |
Articolo in rivista |
Go to |
| 2014 |
Gene expression profiling of cumulus oophorus cells reveals altered pathways in patients with endometriosis |
Proceedings |
Go to |
| 2014 |
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis |
Articolo in rivista |
Go to |
| 2013 |
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions |
Articolo in rivista |
Go to |
| 2013 |
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets |
Articolo in rivista |
Go to |
| 2013 |
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines |
Articolo in rivista |
Go to |
| 2013 |
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? |
Articolo in rivista |
Go to |
| 2013 |
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations |
Articolo in rivista |
Go to |
| 2013 |
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. |
Articolo in rivista |
Go to |
| 2013 |
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. |
Articolo in rivista |
Go to |
| 2012 |
Role of CML exosomes in the crosstalk between chronic myelogenous leukemia and bone-marrow derived exosomes |
Proceedings |
Go to |
| 2012 |
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? |
Articolo in rivista |
Go to |
| 2012 |
Breast cancer genome-wide association studies: there is strength in numbers |
Articolo in rivista |
Go to |
| 2012 |
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies |
Articolo in rivista |
Go to |
| 2012 |
role of CML exosomes in the crosstalk between chronic myelogenous leukaemia and bone marrow-derived cells |
Proceedings |
Go to |
| 2012 |
Gene signatures in CRC and liver metastasis |
Capitolo o Saggio |
Go to |
| 2012 |
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies |
Capitolo o Saggio |
Go to |
| 2012 |
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells |
Articolo in rivista |
Go to |
| 2010 |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? |
Articolo in rivista |
Go to |
| 2010 |
Anti-endothelin drugs in solid tumors |
Articolo in rivista |
Go to |
| 2010 |
VUS variants in BRCA genes of hereditary breast/ovarian cancer |
Proceedings |
Go to |
| 2010 |
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair |
Articolo in rivista |
Go to |
| 2010 |
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE |
Abstract in rivista |
Go to |
| 2009 |
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells |
Abstract in rivista |
Go to |
| 2009 |
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations |
Abstract in rivista |
Go to |
| 2009 |
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles |
Abstract in rivista |
Go to |
| 2009 |
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling |
Abstract in rivista |
Go to |
| 2009 |
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells |
Proceedings |
Go to |
| 2009 |
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell |
Abstract in rivista |
Go to |
| 2008 |
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. |
Capitolo o Saggio |
Go to |
| 2007 |
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) |
Proceedings |
Go to |
| 2007 |
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression |
Proceedings |
Go to |
| 2007 |
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) |
Proceedings |
Go to |
| 2007 |
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) |
Proceedings |
Go to |
| 2007 |
The role of Aurora-A inhibitors in cancer therapy. |
Articolo in rivista |
Go to |
| 2007 |
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. |
Proceedings |
Go to |
| 2007 |
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES |
Proceedings |
Go to |
| 2007 |
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer |
Proceedings |
Go to |
| 2007 |
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER |
Proceedings |
Go to |
| 2007 |
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. |
Proceedings |
Go to |
| 2007 |
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer |
Proceedings |
Go to |
| 2007 |
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. |
Proceedings |
Go to |
| 2007 |
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer |
Proceedings |
Go to |
| 2007 |
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. |
Proceedings |
Go to |
| 2007 |
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS |
Proceedings |
Go to |
